| For: |
Kong YJ, Yi HG, Dai JC, Wei MX. Histological changes of gastric mucosa after |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i19/5903.htm |
| Number | Citing Articles |
| 1 |
|
| 2 |
Duochen Jin, Keting Huang, Miao Xu, Hongjin Hua, Feng Ye, Jin Yan, Guoxin Zhang, Yun Wang. Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota. Gut Microbes 2022; 14(1) doi: 10.1080/19490976.2022.2120744
|
| 3 |
Fujiao Duan, Chunhua Song, Jintao Zhang, Peng Wang, Hua Ye, Liping Dai, Jianying Zhang, Kaijuan Wang. Evaluation of the Epidemiologic Efficacy of EradicatingHelicobacter pylorion Development of Gastric Cancer. Epidemiologic Reviews 2019; 41(1) doi: 10.1093/epirev/mxz006
|
| 4 |
Naoki Sumi, Ken Haruma, Kazuhiko Inoue, Nobumi Hisamoto, Katsuhiro Mabe, Takako Sasai, Toshio Ichiba, Maki Ayaki, Noriaki Manabe, Toshihiro Takao. A case of nodular gastritis progression to autoimmune gastritis after 10 years of Helicobacter pylori eradication. Clinical Journal of Gastroenterology 2024; 17(2) doi: 10.1007/s12328-023-01897-5
|
| 5 |
Yang Cao, Yixin Zheng, Jingbin Niu, Chunmei Zhu, Decai Yang, Fen Rong, Guoping Liu, Girish Sailor. Efficacy of Banxia Xiexin decoction for chronic atrophic gastritis: A systematic review and meta-analysis. PLOS ONE 2020; 15(10) doi: 10.1371/journal.pone.0241202
|
| 6 |
Yongqiang Liang, Yuanhai Yang, Ruiheng Nong, Hao Huang, Xiuyun Chen, Ying Deng, Zhicong Huang, Jingyao Huang, Chunsheng Cheng, Mingzhu Ji, Yinggang Chen, Fulan Hu. Do atrophic gastritis and intestinal metaplasia reverse after Helicobacter pylori eradication?. Helicobacter 2024; 29(1) doi: 10.1111/hel.13042
|
| 7 |
Emanuele Dilaghi, Ludovica Dottori, Giulia Pivetta, Martina Dalla Bella, Gianluca Esposito, Irene Ligato, Emanuela Pilozzi, Bruno Annibale, Edith Lahner. Incidence and Predictors of Gastric Neoplastic Lesions in Corpus-Restricted Atrophic Gastritis: A Single-Center Cohort Study. American Journal of Gastroenterology 2023; 118(12) doi: 10.14309/ajg.0000000000002327
|
| 8 |
Si-Ran Wu, Jie Liu, Li-Feng Zhang, Na Wang, Lu-Yao Zhang, Qiong Wu, Jun-Ye Liu, Yong-Quan Shi. Lamb’s tripe extract and vitamin B<sub>12 </sub>capsule plus celecoxib reverses intestinal metaplasia and atrophy: A retrospective cohort study. World Journal of Clinical Cases 2021; 9(34): 10472-10483 doi: 10.12998/wjcc.v9.i34.10472
|
| 9 |
Kazuhiro Mizukami, Masaaki Kodama, Yuka Hirashita, Masahide Fukuda, Sotaro Ozaka, Koshiro Tsutsumi, Ryota Sagami, Kensuke Fukuda, Ryo Ogawa, Kazunari Murakami. Predictors of the Development of Gastric Cancer in Post-Helicobacter pylori-Eradication Patients Followed Up for More than 10 Years: A Histological, Serological, and Endoscopic Study. Cancers 2025; 17(3) doi: 10.3390/cancers17030552
|
| 10 |
Amit Assa, Osvaldo Borrelli, Ilse Broekaert, Marco Deganello Saccomani, Jernej Dolinsek, Javier Martin‐de‐Carpi, Emmanuel Mas, Erasmo Miele, Sara Sila, Mike Thomson, Christos Tzivinikos, Marc A. Benninga. Helicobacter pylori‐negative Chronic Gastritis in Children. Journal of Pediatric Gastroenterology and Nutrition 2022; 74(5) doi: 10.1097/MPG.0000000000003414
|
| 11 |
Hiroto Kinoshita, Yoku Hayakawa, Kazuhiko Koike. Metaplasia in the Stomach—Precursor of Gastric Cancer?. International Journal of Molecular Sciences 2017; 18(10) doi: 10.3390/ijms18102063
|
| 12 |
Hyo-Joon Yang. Helicobacter pylori Eradication after Endoscopic Resection of Early Gastric Cancer: Long-standing Questions, Clear Answers. The Korean Journal of Gastroenterology 2018; 71(6) doi: 10.4166/kjg.2018.71.6.363
|
| 13 |
Shida Haghighat, Catherine Blandon, David Goldberg, Shria Kumar. Association between country of birth and gastric intestinal metaplasia: a retrospective cohort study. The Lancet Regional Health - Americas 2023; 28 doi: 10.1016/j.lana.2023.100635
|
| 14 |
Shivaram Prasad Singh, Vineet Ahuja, Uday C. Ghoshal, Govind Makharia, Usha Dutta, Showkat Ali Zargar, Jayanthi Venkataraman, Amit Kumar Dutta, Asish K Mukhopadhyay, Ayaskanta Singh, Babu Ram Thapa, Kim Vaiphei, Malathi Sathiyasekaran, Manoj K. Sahu, Niranjan Rout, Philip Abraham, Prakash Chandra Dalai, Pravin Rathi, Saroj K. Sinha, Shobna Bhatia, Susama Patra, Ujjala Ghoshal, Ujjal Poddar, Venigalla Pratap Mouli, Vikram Kate. Management of Helicobacter pylori infection: The Bhubaneswar Consensus Report of the Indian Society of Gastroenterology. Indian Journal of Gastroenterology 2021; 40(4) doi: 10.1007/s12664-021-01186-4
|
| 15 |
Miao Yu, Jing Ma, Xiao-Xia Song, Qiao-Qiao Shao, Xue-Chun Yu, Muhammad Noman Khan, Ya-Bin Qi, Ruo-Bing Hu, Pei-Ru Wei, Wei Xiao, Bai-Ling Jia, Yan-Bo Cheng, Ling-Fei Kong, Chuan-Liang Chen, Song-Ze Ding. Gastric mucosal precancerous lesions in <i>Helicobacter pylori</i>-infected pediatric patients in central China: A single-center, retrospective investigation. World Journal of Gastroenterology 2022; 28(28): 3682-3694 doi: 10.3748/wjg.v28.i28.3682
|
| 16 |
Soie Chung, Jung Kim, Ji Hyun Song, Jooyoung Lee, Sun Young Yang, Eun Young Song. Longitudinal Changes in the Serum Pepsinogen I/II Ratio With Progression of Gastric Atrophy. Journal of Clinical Laboratory Analysis 2026; 40(13) doi: 10.1002/jcla.70264
|
| 17 |
Ting-Ting Huang, Yan-Ni Liu, Jin-Xian Huang, Ping-Ping Yan, Ji-Jing Wang, Yong-Xiao Cao, Lei Cao. Sodium sulfite-driven Helicobacter pylori eradication: Unraveling oxygen dynamics through multi-omics investigation. Biochemical Pharmacology 2024; 222 doi: 10.1016/j.bcp.2024.116055
|
| 18 |
Sangeeta Agrawal. Gastric Intestinal Metaplasia and Helicobacter Pylori Testing. Gastroenterology & Hepatology: Open Access 2016; 4(6) doi: 10.15406/ghoa.2016.04.00121
|
| 19 |
Т. L. Lapina, V. T. Ivashkin. Rebamipide during chronic gastritis: <i>H. pylori</i> eradication therapy and restoration of gastric mucosa barrier function. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2024; 33(6) doi: 10.22416/1382-4376-2023-33-6-81-87
|
| 20 |
Kichul Yoon, Nayoung Kim. Significance of Helicobacter pylori Eradication on Atrophic Gastritis and Intestinal Metaplasia. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2020; 20(2) doi: 10.7704/kjhugr.2020.0018
|
| 21 |
Bokyung Kim. Effect of Helicobacter pylori Treatment on Gastric Cancer Incidence and Mortality. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2025; 25(4) doi: 10.7704/kjhugr.2025.0052
|
| 22 |
Samir Gupta, Dan Li, Hashem B. El Serag, Perica Davitkov, Osama Altayar, Shahnaz Sultan, Yngve Falck-Ytter, Reem A. Mustafa. AGA Clinical Practice Guidelines on Management of Gastric Intestinal Metaplasia. Gastroenterology 2020; 158(3) doi: 10.1053/j.gastro.2019.12.003
|
| 23 |
Muhammad Y. Khan, Aysha Aslam, Albana B. Mihali, Muhammad Shabbir Rawala, Ahmed Dirweesh, Salman Khan, Douglas G. Adler, Ali Siddiqui. Effectiveness of Helicobacter pylori eradication in preventing metachronous gastric cancer and preneoplastic lesions. A systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2020; 32(6) doi: 10.1097/MEG.0000000000001740
|
| 24 |
Chang Seok Bang, Gwang Ho Baik. <i>Helicobacter Pylori</i> Infection and Related Gastrointestinal Diseases. The Korean Journal of Medicine 2015; 89(2) doi: 10.3904/kjm.2015.89.2.142
|
| 25 |
Elena A. Kupriyanova, Sayar R. Abdulkhakov, Ruzilya К. Ismagilova, Dilyara D. Safina, Alsu R. Akhtereeva, Raushania R. Galimova, Ayrat G. Safin, Tatiana V. Grigoryeva, Rustam А. Abdulkhakov. The prevalence of mutations underlying development of Helicobacter pylori resistance to antibiotics in Kazan. Terapevticheskii arkhiv 2024; 96(8) doi: 10.26442/00403660.2024.08.202813
|
| 26 |
Beom Jin Kim. Natural Course of Atrophic Gastritis and Intestinal Metaplasia. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2020; 20(2) doi: 10.7704/kjhugr.2020.0024
|
| 27 |
Ruchir Paladiya, Pradeep K. Siddappa, John W. Birk. Healthy Aging. 2026; doi: 10.1007/978-3-032-21928-2_7
|
| 28 |
Jie Chen, Gansheng Zhang, Jian Qin, Yiqin Huang, Yu Wang, Zhongkuo Li, Danian Ji, Li Xiao, Shuming Yin, Zhijun Bao. Long-term effects and benefits of Helicobacter pylori eradication on the gastric mucosa in older individuals. Saudi Journal of Gastroenterology 2022; 28(2) doi: 10.4103/sjg.sjg_206_21
|
| 29 |
D. N. Andreev, Yu. A. Kucheryavyy, I. V. Maev. Efficacy of butyric acid inclusion in eradication regimens for <i>Helicobacter pylori </i>infection: a meta-analysis of controlled trials. Terapevticheskii arkhiv 2021; 93(2) doi: 10.26442/00403660.2021.02.200608
|
| 30 |
Nicolas Chapelle, Matthieu Péron, Lucille Quénéhervé, Alice Bourget, Maxime Leroy, Yann Touchefeu, Estelle Cauchin, Emmanuel Coron, Jean François Mosnier, Tamara Matysiak-Budnik. Long-Term Follow-up of Gastric Precancerous Lesions in a Low GC Incidence Area. Clinical and Translational Gastroenterology 2020; 11(12) doi: 10.14309/ctg.0000000000000237
|
| 31 |
Junyi Li, Xiaoyan Xu, Shiyu Yang, Kui Liu, Min Wu, Mingyong Xie, Tao Xiong. Helicobacter pylori Inhibition, Gastritis Attenuation, and Gut Microbiota Protection in C57BL/6 Mice by Ligilactobacillus salivarius NCUH062003. Microorganisms 2024; 12(12) doi: 10.3390/microorganisms12122521
|
| 32 |
Chang Seok Bang, Gwang Ho Baik. Trends of Meta-analysis in Upper Gastrointestinal Diseases. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2015; 15(2) doi: 10.7704/kjhugr.2015.15.2.80
|
| 33 |
Shinji Kitamura, Naoki Muguruma, Koichi Okamoto, Toshihito Tanahashi, Akira Fukuya, Kumiko Tanaka, Daisaku Fujimoto, Tetsuo Kimura, Hiroshi Miyamoto, Yoshimi Bando, Hisashi Takeuchi, Masako Shiba, Tetsuji Takayama. Clinicopathological Assessment of Gastric Xanthoma as Potential Predictive Marker of Gastric Cancer. Digestion 2017; 96(4) doi: 10.1159/000481346
|
| 34 |
Gitark Noh, Nayoung Kim, Yonghoon Choi, Hye Seung Lee, Young Jae Hwang, Hee Jin Kim, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee. Long‐term follow up of serum pepsinogens in patients with gastric cancer or dysplasia after Helicobacter pylori eradication. Journal of Gastroenterology and Hepatology 2020; 35(9) doi: 10.1111/jgh.15017
|
| 35 |
Kevin Sze-Hang Liu, Irene Oi-Ling Wong, Wai K Leung. <i>Helicobacter pylori</i> associated gastric intestinal metaplasia: Treatment and surveillance. World Journal of Gastroenterology 2016; 22(3): 1311-1320 doi: 10.3748/wjg.v22.i3.1311
|
| 36 |
Santiago García Carmona, Juan Carlos Arango Viana, Enoc Jesús Ahumada Rodríguez, Jessenia Agudelo Mesa, Tania Liseth Pérez Cala, Alonso Martínez, Sigifredo Ospina Ospina, Beatriz Eugenia Salazar Giraldo. Utilidad de la coloración de Giemsa para diagnosticar Helicobacter pylori en pacientes con lesiones preneoplásicas. Revista colombiana de Gastroenterología 2022; 37(4) doi: 10.22516/25007440.938
|
| 37 |
Yuan Li, Yili Zhang, Han Meng, Mengting Liao, Zeqi Su, Mengyin Zhai, Lingling Jiang, Ping Li, Xia Ding. Efficacy and safety of acupuncture therapy for chronic atrophic gastritis. Medicine 2019; 98(35) doi: 10.1097/MD.0000000000017003
|
| 38 |
Hang Yang, Yi Mou, Bing Hu. Discussion on the common controversies of Helicobacter pylori infection. Helicobacter 2023; 28(1) doi: 10.1111/hel.12938
|
| 39 |
Longhua Wang, Xia Ding, Ping Li, Fuwen Zhang, Shuying Ru, Fenglei Wang, Lan Li, Mohamed Ezzat Abd El-Hack. Efficacy and safety of Weifuchun tablet for chronic atrophic gastritis: A systematic review and meta-analysis. PLOS ONE 2023; 18(4) doi: 10.1371/journal.pone.0284411
|
| 40 |
N. Aytekin, K. N. Mileva, A. D. Cunliffe. Selected B vitamins and their possible link to the aetiology of age-related sarcopenia: relevance of UK dietary recommendations. Nutrition Research Reviews 2018; 31(2) doi: 10.1017/S0954422418000045
|
| 41 |
Inês Pita, Diogo Libânio, Pedro Pimentel Nunes. Diagnosis and Management of Epithelial Precancerous Conditions and Lesions in the Stomach. Current Treatment Options in Gastroenterology 2021; 19(2) doi: 10.1007/s11938-021-00341-2
|
| 42 |
Ufuk Kutluana, Ayse Guldem Kilciler, Soycan Mizrak, Utku Dilli. Can neopterin be a useful immune biomarker for differentiating gastric intestinal metaplasia and gastric atrophy from non-atrophic non-metaplastic chronic gastritis?. Gastroenterología y Hepatología 2019; 42(5) doi: 10.1016/j.gastrohep.2019.01.005
|
| 43 |
Anthony O’Connor, Adam Bowden, Eoin Farrell, Joshua Weininger, Stephen Crowther, Deirdre McNamara, Paul Ridgway, Colm O’Morain. Risk of Progression of Gastric Intestinal Metaplasia Is Significantly Greater When Detected in Both Antrum and Body. Digestive Diseases and Sciences 2021; 66(10) doi: 10.1007/s10620-020-06659-8
|
| 44 |
Yeon-Ji Kim, Jaeyoung Kim, Woo Chul Chung. Clinical outcomes of metachronous recurrence of gastric epithelial neoplasia based on Helicobacter pylori infection status and microsatellite stability. The Korean Journal of Internal Medicine 2022; 37(4) doi: 10.3904/kjim.2021.229
|
| 45 |
Yong He, Xin Wang, Li-Sheng Chen, Lei Chang, Ting-Ting He, Ao-Zhe Zhang, Hao-Tian Li, Shi-Zhang Wei, Man-Yi Jing, Yan-Ling Zhao. Effects of Rutaecarpine on Chronic Atrophic Gastritis Through Nucleotide-binding Oligomerization Domain-like Receptors and Inflammasomes. World Journal of Traditional Chinese Medicine 2024; 10(3) doi: 10.4103/wjtcm.wjtcm_55_24
|
| 46 |
Airu Liu, Yuxin Wang, Yingxiao Song, Yiqi Du. Treatment with compound Lactobacillus acidophilus followed by a tetracycline- and furazolidone-containing quadruple regimen as a rescue therapy for Helicobacter pylori infection. Saudi Journal of Gastroenterology 2020; 26(2) doi: 10.4103/sjg.SJG_589_19
|
| 47 |
Kichul Yoon, Nayoung Kim. Reversibility of Atrophic Gastritis and Intestinal Metaplasia by Eradication ofHelicobacter pylori. The Korean Journal of Gastroenterology 2018; 72(3) doi: 10.4166/kjg.2018.72.3.104
|
| 48 |
Y.‐J. Hwang, N. Kim, H. S. Lee, J. B. Lee, Y. J. Choi, H. Yoon, C. M. Shin, Y. S. Park, D. H. Lee. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication ‐ a prospective study for up to 10 years. Alimentary Pharmacology & Therapeutics 2018; 47(3) doi: 10.1111/apt.14424
|
| 49 |
Dustin E Bosch, Niklas Krumm, Mark H Wener, Matthew M Yeh, Camtu D Truong, Deepti M Reddi, Yongjun Liu, Paul E Swanson, Rodney A Schmidt, Andrew Bryan. Serology Is More Sensitive Than Urea Breath Test or Stool Antigen for the Initial Diagnosis of Helicobacter pylori Gastritis When Compared With Histopathology. American Journal of Clinical Pathology 2020; 154(2) doi: 10.1093/ajcp/aqaa043
|
| 50 |
Ashutosh Gupta, Moumita Saha, Shivani Shailesh Kunkalienkar, Aadarsh Ghurye, Shweta Verma, Jahnavy Joshi, Abhishek Jha, Srinivas Mutalik, Shiran Shetty, Raghu Chandrashekar Hariharapura, Ashwini Aithal, K Nandakumar, Raviraja N. Seetharam, Sudheer Moorkoth. Design and Characterization of Novel Gastroretentive Drug Delivery System of Antibiotics and Piperine for the Eradication of H. pylori Infection. Molecular Pharmaceutics 2025; 22(12) doi: 10.1021/acs.molpharmaceut.5c01253
|
| 51 |
|
| 52 |
Young‐Il Kim, Jong Yeul Lee, Chan Gyoo Kim, Myeong‐Cherl Kook, Boram Park, Il Ju Choi. Long‐Term Effect of Helicobacter pylori Eradication on Gastric Atrophy and Intestinal Metaplasia After Endoscopic Resection of Gastric Neoplasm: A Follow‐Up of a Randomized Controlled Trial. Helicobacter 2026; 31(3) doi: 10.1111/hel.70139
|
| 53 |
Akiko Kowada, Masahiro Asaka. Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost‐effectiveness analysis. Helicobacter 2021; 26(5) doi: 10.1111/hel.12837
|
| 54 |
V. T. Ivashkin, I. V. Maev, T. L. Lapina, E. D. Fedorov, A. A. Sheptulin, A. S. Trukhmanov, A. V. Kononov, R. A. Abdulkhakov, O. P. Alexeeva, S. A. Alekseenko, D. N. Andreev, E. K. Baranskaya, N. N. Dekhnich, I. L. Klyaritskaya, R. S. Kozlov, E. A. Kogan, M. P. Korolev, N. V. Korochanskaya, S. A. Kurilovich, M. A. Livsan, M. F. Osipenko, P. V. Pavlov, S. S. Pirogov, A. S. Sarsenbaeva, V. I. Simanenkov, A. S. Tertychny, A. V. Tkachev, Yu. P. Uspensky, I. B. Khlynov, V. V. Tsukanov. Clinical Recommendations of Russian Gastroenterological Association and RENDO Endoscopic Society on Diagnosis and Treatment of Gastritis and Duodenitis. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2021; 31(4) doi: 10.22416/1382-4376-2021-31-4-70-99
|
| 55 |
Mário Dinis-Ribeiro, Diogo Libânio, Hugo Uchima, Manon C.W. Spaander, Jan Bornschein, Tamara Matysiak-Budnik, Georgios Tziatzios, João Santos-Antunes, Miguel Areia, Nicolas Chapelle, Gianluca Esposito, Gloria Fernandez-Esparrach, Lumir Kunovsky, Mónica Garrido, Ilja Tacheci, Alexander Link, Pedro Marcos, Ricardo Marcos-Pinto, Leticia Moreira, Ana Carina Pereira, Pedro Pimentel-Nunes, Marcin Romanczyk, Filipa Fontes, Cesare Hassan, Raf Bisschops, Roger Feakins, Christian Schulz, Konstantinos Triantafyllou, Fatima Carneiro, Ernst J. Kuipers. Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025. Endoscopy 2025; 57(05) doi: 10.1055/a-2529-5025
|
| 56 |
Seung Jun Han, Sang Gyun Kim, Joo Hyun Lim, Ji Min Choi, Sooyeon Oh, Jae Yong Park, Jung Kim, Joo Sung Kim, Hyun Chae Jung. Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development. Gut and Liver 2018; 12(2) doi: 10.5009/gnl17073
|
| 57 |
Yasuhiro Wada, Ryoji Kushima, Masaaki Kodama, Masahide Fukuda, Kensuke Fukuda, Kazuhisa Okamoto, Ryo Ogawa, Kazuhiro Mizukami, Tadayoshi Okimoto, Kazunari Murakami. Histological changes associated with pyloric and pseudopyloric metaplasia after Helicobacter pylori eradication. Virchows Archiv 2020; 477(4) doi: 10.1007/s00428-020-02805-9
|
| 58 |
Masaaki Kodama, Tadayoshi Okimoto, Kazuhiro Mizukami, Hisanori Abe, Ryo Ogawa, Kazuhisa Okamoto, Mitsutaka Shuto, Osamu Matsunari, Yuka Hirashita, Ryugo Sato, Takashi Abe, Takayuki Nagai, Tsuyoshi Arita, Kazunari Murakami. Endoscopic and Immunohistochemical Characteristics of Gastric Cancer with versus without Helicobacter Pylori Eradication. Digestion 2018; 97(4) doi: 10.1159/000485504
|
| 59 |
V. T. Ivashkin, T. L. Lapina, I. V. Maev, O. M. Drapkina, R. S. Kozlov, A. A. Sheptulin, A. S. Trukhmanov, S. R. Abdulkhakov, O. P. Alekseeva, S. A. Alekseenko, D. N. Andreev, D. S. Bordin, N. N. Dekhnich, I. L. Klyaritskaya, N. V. Korochanskaya, M. F. Osipenko, E. A. Poluektova, A. S. Sarsenbaeva, V. I. Simanenkov, A. V. Tkachev, A. I. Ulyanin, I. B. Khlynov, V. V. Tsukanov. Clinical Practice Guidelines of Russian Gastroenterological Association, Scientific Society for the Clinical Study of Human Microbiome, Russian Society for the Prevention of Non-Communicable Diseases, Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy for <i>H. pylori</i> Diagnostics and Treatment in Adults. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(6) doi: 10.22416/1382-4376-2022-32-6-72-93
|
| 60 |
|
| 61 |
A. A. Svistunov, N. V. Kireeva, M. A. Osadchuk. The role of diffuse neuroendocrine system of the digestive tract in the
development of disorders of proliferation and apoptosis in the stomach of patients with Helicobacter pylori infection. Clinical Medicine (Russian Journal) 2017; 95(4) doi: 10.18821/0023-2149-2017-95-4-316-321
|
| 62 |
Massimo Rugge, Alberto Meggio, Cecilia Pravadelli, Mattia Barbareschi, Matteo Fassan, Maria Gentilini, Manuel Zorzi, Giovanni De Pretis, David Y Graham, Robert M Genta. Gastritis staging in the endoscopic follow-up for the secondary prevention of gastric cancer: a 5-year prospective study of 1755 patients. Gut 2019; 68(1) doi: 10.1136/gutjnl-2017-314600
|
| 63 |
Jihee Sung, Nayoung Kim, Jongchan Lee, Young-Jae Hwang, Hyoung Woo Kim, Jung Wha Chung, Jin-Wook Kim, Dong Ho Lee. Associations among Gastric Juice pH, Atrophic Gastritis, Intestinal Metaplasia andHelicobacter pyloriInfection. Gut and Liver 2018; 12(2) doi: 10.5009/gnl17063
|
| 64 |
Ryota Niikura, Yoku Hayakawa, Yoshihiro Hirata, Keiji Ogura, Mitsuhiro Fujishiro, Atsuo Yamada, Tetsuo Ushiku, Mitsuru Konishi, Masashi Fukayama, Kazuhiko Koike. The Reduction in Gastric Atrophy after Helicobacter pylori Eradication Is Reduced by Treatment with Inhibitors of Gastric Acid Secretion. International Journal of Molecular Sciences 2019; 20(8) doi: 10.3390/ijms20081913
|
| 65 |
Kiarash Ghazvini, Masoud Keikha. The impact of Helicobacter pylori eradication on gastric mucosa histology from the meta-analyses perspective – Correspondence. International Journal of Surgery 2022; 104 doi: 10.1016/j.ijsu.2022.106785
|
| 66 |
Rajbir Singh, Iyshwarya Balasubramanian, Lanjing Zhang, Nan Gao. Metaplastic Paneth Cells in Extra-Intestinal Mucosal Niche Indicate a Link to Microbiome and Inflammation. Frontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.00280
|
| 67 |
Nastaran Farzi, Catherine Behzad, Zahra Hasani, Masoud Alebouyeh, Homayoun Zojaji, Mohammad Reza Zali. Characterization of clarithromycin heteroresistance among Helicobacter pylori strains isolated from the antrum and corpus of the stomach. Folia Microbiologica 2019; 64(2) doi: 10.1007/s12223-018-0637-9
|
| 68 |
Masaaki Kodama, Tadayoshi Okimoto, Kazuhiro Mizukami, Yuka Hirashita, Yasuhiro Wada, Masahide Fukuda, Osamu Matsunari, Kazuhisa Okamoto, Ryo Ogawa, Kensuke Fukuda, Yoko Kudo, Yoshinari Kawahara, Kazunari Murakami. Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long‐term prospective follow‐up study. Journal of Gastroenterology and Hepatology 2021; 36(8) doi: 10.1111/jgh.15477
|
| 69 |
P Malfertheiner, F Megraud, C A O'Morain, J P Gisbert, E J Kuipers, A T Axon, F Bazzoli, A Gasbarrini, J Atherton, D Y Graham, R Hunt, P Moayyedi, T Rokkas, M Rugge, M Selgrad, S Suerbaum, K Sugano, E M El-Omar. Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report. Gut 2017; 66(1) doi: 10.1136/gutjnl-2016-312288
|
| 70 |
I. G. Bakulin, S. S. Pirogov, N. V. Bakulina, E. A. Stadnik, N. N. Golubev. Prophylaxis and early diagnosis of stomach cancer. Dokazatel'naya gastroenterologiya 2018; 7(2) doi: 10.17116/dokgastro201872244
|
| 71 |
Juan Camilo Caguazango, Álvaro Jairo Pazos. La microbiota según la topografía gástrica en pacientes con bajo y con alto riesgo de cáncer gástrico en Nariño, Colombia. Biomédica 2019; 39(Supl. 2) doi: 10.7705/biomedica.v39i4.4520
|
| 72 |
Ufuk Kutluana, Ayse Guldem Kilciler, Soycan Mizrak, Utku Dilli. Can neopterin be a useful immune biomarker for differentiating gastric intestinal metaplasia and gastric atrophy from non-atrophic non-metaplastic chronic gastritis?. Gastroenterología y Hepatología (English Edition) 2019; 42(5) doi: 10.1016/j.gastre.2019.05.001
|
| 73 |
Satoki Shichijo, Yoshihiro Hirata, Ryota Niikura, Yoku Hayakawa, Atsuo Yamada, Tetsuo Ushiku, Masashi Fukayama, Kazuhiko Koike. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication. Gastrointestinal Endoscopy 2016; 84(4) doi: 10.1016/j.gie.2016.03.791
|
| 74 |
Yong He, Hong-Hong Liu, Xue-Lin Zhou, Ting-Ting He, Ao-Zhe Zhang, Xin Wang, Shi-Zhang Wei, Hao-Tian Li, Li-Sheng Chen, Lei Chang, Yan-Ling Zhao, Man-Yi Jing. Rutaecarpine Ameliorates Murine N-Methyl-N’-Nitro-N-Nitrosoguanidine-Induced Chronic Atrophic Gastritis by Sonic Hedgehog Pathway. Molecules 2023; 28(17) doi: 10.3390/molecules28176294
|
| 75 |
Bruno Annibale, Emanuele Dilaghi, Edith Lahner. The Rose and Mackay Textbook of Autoimmune Diseases. 2024; doi: 10.1016/B978-0-443-23947-2.00033-3
|
| 76 |
Agnes Maganga, Solomon Boamah, Jianjun Wu, Bilembi Mboté Olivier. Risk factors and correlation of intestinal metaplasia: A case- control study in Wuwei. Arab Journal of Gastroenterology 2025; 26(2) doi: 10.1016/j.ajg.2025.02.004
|
| 77 |
Jennifer T. Higa, Joo Ha Hwang. Gastric intestinal metaplasia: An irreversible risk factor for gastric cancer?. Gastrointestinal Endoscopy 2016; 84(4) doi: 10.1016/j.gie.2016.04.028
|
| 78 |
You Wu, Xiao Yang Dong, Xian Zhu Zhou, Zhao Shen Li, Yi Qi Du. Effects of probiotics on gastric microbiota and its precombination with quadruple regimen for Helicobacter pylori eradication. Journal of Digestive Diseases 2022; 23(8-9) doi: 10.1111/1751-2980.13138
|
| 79 |
Eri Iwata, Mitsushige Sugimoto, Yoshika Akimoto, Mariko Hamada, Ryota Niikura, Naoyoshi Nagata, Kyosuke Yanagisawa, Takao Itoi, Takashi Kawai. Long-term endoscopic gastric mucosal changes up to 20 years after Helicobacter pylori eradication therapy. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-63928-6
|
| 80 |
M. Selgrad, M. Müller-Schilling. Präneoplastische Bedingungen des Magens. Der Gastroenterologe 2018; 13(2) doi: 10.1007/s11377-018-0234-0
|
| 81 |
Fangyuan Zhu, Xiaoze Zhang, Ping Li, Yaodong Zhu. Effect of Helicobacter pylori eradication on gastric precancerous lesions: A systematic review and meta‐analysis. Helicobacter 2023; 28(6) doi: 10.1111/hel.13013
|
| 82 |
Emanuele DILAGHI, Gianluca ESPOSITO, Gianluca FRANCHELLUCCI, Bruno ANNIBALE, Angelo ZULLO. Gastric juice analysis in clinical practice: are we ready for the prime time?. Minerva Gastroenterology 2025; 71(2) doi: 10.23736/S2724-5985.25.03861-6
|
| 83 |
Ammiel Martínez Canil, Angelo Iossa, Pietro Termine, Daniela Caporilli, Vincenzo Petrozza, Gianfranco Silecchia. Histopathology Findings in Patients Undergoing Laparoscopic Sleeve Gastrectomy. Obesity Surgery 2018; 28(6) doi: 10.1007/s11695-017-3092-9
|
| 84 |
Zong-ge Sha, Sen Lin, Zhi-liang Fan, Ze-Chun Yang, Ye-tao Gong, Tao Qin, Rong Yu, Yong He. Efficacy and potential mechanisms of jatrorrhizine on MNNG-induced chronic atrophic gastritis in rats based on serological metabolomics and molecular docking. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-05502-2
|
| 85 |
Natsuda Aumpan, Ratha-korn Vilaichone, Bubpha Pornthisarn, Soonthorn Chonprasertsuk, Sith Siramolpiwat, Patommatat Bhanthumkomol, Pongjarat Nunanan, Navapan Issariyakulkarn, Sarita Ratana-Amornpin, Muhammad Miftahussurur, Varocha Mahachai, Yoshio Yamaoka, Pal Bela Szecsi. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial). PLOS ONE 2021; 16(8) doi: 10.1371/journal.pone.0255601
|
| 86 |
Ji Min Choi, Sang Gyun Kim. Helicobacter pylori Eradication after Endoscopic Resection of Gastric Epithelial Neoplasms. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2019; 19(4) doi: 10.7704/kjhugr.2019.0020
|
| 87 |
Yury P. Uspenskiy, Natalia V. Baryshnikova, Alexey A. Krasnov, Sergey V. Petlenko, Vera A. Apryatina. Topical issues of prevention of stomach cancer: A review. Consilium Medicum 2022; 24(5) doi: 10.26442/20751753.2022.5.201922
|
| 88 |
Maya Granot, Beate C. Beinvogl, Michael Schvimer, Jeffrey D. Goldsmith, Manar Matar, Amir Ben Tov, Anat Y. Feler, Nurit Nachum, Sara Morgenstern, Chen Mayer, Raanan Shamir, Batia Weiss, Dror S. Shouval. Clinical characteristics and outcomes of pediatric patients with autoimmune gastritis. Journal of Pediatric Gastroenterology and Nutrition 2024; 79(3) doi: 10.1002/jpn3.12318
|
| 89 |
Hang Yang, Xinyue Zhou, Bing Hu. The ‘reversibility’ of chronic atrophic gastritis after the eradication ofHelicobacter pylori. Postgraduate Medicine 2022; 134(5) doi: 10.1080/00325481.2022.2063604
|
| 90 |
Masaaki Kodama, Osamu Handa, Mitsushige Sugimoto, Takahiro Kotachi, Masaaki Kobayashi, Susumu Take, Shu Hoteya, Katsuhiro Mabe, Takahisa Murao, Ken Namikawa, Takashi Kawai, Kazunari Murakami. Endoscopic risk factors to inform early detection of gastric cancer after Helicobacter pylori eradication: Meta‐analysis and systematic review. DEN Open 2025; 5(1) doi: 10.1002/deo2.70086
|
| 91 |
Te-Ling Ma, Wei-Chen Tai, Song-Seng Loke, Chih-Chien Yao, Chih-Ming Liang, Seng-Kee Chuah. Efficacy and Safety of 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Helicobacter pylori Eradication in the Elderly. Drugs & Aging 2023; 40(1) doi: 10.1007/s40266-022-00990-7
|
| 92 |
Doffou Adjéka Stanislas, Constant Assi, Hamidine Illa, Antonin Wilson Ndjitoyap Ndam, Bangoura Aboubacar Demba, Nigue Luc, Attia Koffi Alain. Impact of quadruple eradication therapy on the elements of the Sydney system in chronic Helicobacter pylori gastritis in Abidjan (Ivory Coast). Nigerian Journal of Gastroenterology and Hepatology 2021; 13(2) doi: 10.4103/njgh.njgh_5_21
|
| 93 |
Chun-Yan Weng, Jing-Li Xu, Shao-Peng Sun, Kai-Jie Wang, Bin Lv. <i>Helicobacter pylori </i>eradication: Exploring its impacts on the gastric mucosa. World Journal of Gastroenterology 2021; 27(31): 5152-5170 doi: 10.3748/wjg.v27.i31.5152
|
| 94 |
Anthony O'Connor, Colm A. O'Morain, Alexander C. Ford. Population screening and treatment of Helicobacter pylori infection. Nature Reviews Gastroenterology & Hepatology 2017; 14(4) doi: 10.1038/nrgastro.2016.195
|
| 95 |
Yo Han Park, Nayoung Kim. Review of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer. Journal of Cancer Prevention 2015; 20(1) doi: 10.15430/JCP.2015.20.1.25
|
| 96 |
|
| 97 |
Jong Kyu Park.
Helicobacter pylori Eradication Prevents the Occurrence of Metachronous Gastric Cancer. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2018; 18(2) doi: 10.7704/kjhugr.2018.18.2.144
|
| 98 |
Hyo-Joon Yang. Exploring the Link between Helicobacter pylori Eradication and Metachronous Gastric Cancer Development. Gut and Liver 2018; 12(2) doi: 10.5009/gnl17493
|
| 99 |
Yali Wei, Chen Jiang, Yiping Han, Wen Song, Xiaoyu Li, Xiaoyan Yin. Characteristics and background mucosa status of early gastric cancer after Helicobacter pylori eradication: A narrative review. Medicine 2022; 101(48) doi: 10.1097/MD.0000000000031968
|
| 100 |
Il Ju Choi, Myeong-Cherl Kook, Young-Il Kim, Soo-Jeong Cho, Jong Yeul Lee, Chan Gyoo Kim, Boram Park, Byung-Ho Nam.
Helicobacter pylori
Therapy for the Prevention of Metachronous Gastric Cancer
. New England Journal of Medicine 2018; 378(12) doi: 10.1056/NEJMoa1708423
|
| 101 |
Fariba Fayaz, Latif Gachkar, Sara Rahmati Roodsari, Bita Pourkaveh. Prevalence of Helicobacter pylori Infection in Patients With Down Syndrome and Mental Retardation. Archives of Clinical Infectious Diseases 2014; 9(4) doi: 10.5812/archcid.22064
|